IRIS
FILIPPI, ANDREA RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.855
AS - Asia 1.895
EU - Europa 1.336
SA - Sud America 292
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.774
SG - Singapore 619
IE - Irlanda 556
CN - Cina 479
HK - Hong Kong 292
VN - Vietnam 238
BR - Brasile 215
RU - Federazione Russa 204
FR - Francia 120
ZA - Sudafrica 119
DE - Germania 113
IT - Italia 87
IN - India 75
FI - Finlandia 71
CA - Canada 49
GB - Regno Unito 38
BD - Bangladesh 37
SE - Svezia 31
CZ - Repubblica Ceca 28
IQ - Iraq 28
AR - Argentina 23
MX - Messico 22
TR - Turchia 21
JP - Giappone 18
NL - Olanda 17
PK - Pakistan 15
EC - Ecuador 13
BE - Belgio 12
CO - Colombia 12
SA - Arabia Saudita 12
PL - Polonia 11
AT - Austria 10
CL - Cile 10
ID - Indonesia 10
MA - Marocco 10
KE - Kenya 9
LT - Lituania 8
PH - Filippine 8
VE - Venezuela 7
UA - Ucraina 6
AZ - Azerbaigian 5
ES - Italia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
BO - Bolivia 3
EU - Europa 3
HU - Ungheria 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
UY - Uruguay 3
AM - Armenia 2
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GM - Gambi 1
GN - Guinea 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KR - Corea 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MM - Myanmar 1
MU - Mauritius 1
NC - Nuova Caledonia 1
OM - Oman 1
SO - Somalia 1
TN - Tunisia 1
TW - Taiwan 1
TZ - Tanzania 1
YE - Yemen 1
Totale 6.538
Salva come PNG Salva come JPEG
Città #
Dublin 555
Ashburn 410
San Jose 358
Chandler 334
Hong Kong 285
Singapore 282
Dallas 169
Beijing 155
Boardman 119
Princeton 116
Johannesburg 111
Lauterbourg 100
Lawrence 98
Ho Chi Minh City 89
Medford 80
Los Angeles 64
Wilmington 64
Shanghai 63
Hanoi 50
Washington 49
Helsinki 45
Buffalo 44
Munich 44
Redondo Beach 44
New York 34
Moscow 25
Toronto 25
Turku 25
São Paulo 23
Brno 22
Pavia 22
Santa Clara 21
Norwalk 18
Nuremberg 17
Ann Arbor 16
Chicago 16
Tokyo 16
Stockholm 15
London 14
Milan 14
Frankfurt am Main 13
Orem 13
The Dalles 13
Chennai 12
Brussels 11
Council Bluffs 11
Dhaka 11
Haiphong 11
Columbus 10
Falkenstein 10
Guangzhou 10
New Delhi 10
Saint Louis 10
Atlanta 9
Baghdad 9
Mexico City 9
Nairobi 9
Rio de Janeiro 9
Ankara 8
Düsseldorf 8
Phoenix 8
Seattle 8
Amsterdam 7
Boston 7
Brooklyn 7
Denver 7
Houston 7
Montreal 7
Vienna 7
Warsaw 7
Zhengzhou 7
Belo Horizonte 6
Da Nang 6
Erbil 6
Guayaquil 6
Lahore 6
Pune 6
Redwood City 6
Baku 5
Canyon Country 5
Jakarta 5
Jeddah 5
Olomouc 5
Casablanca 4
Changsha 4
Chengdu 4
Curitiba 4
Dong Ket 4
Goiânia 4
Ludhiana 4
Ottawa 4
Riyadh 4
Shenzhen 4
Tashkent 4
Tianjin 4
Amman 3
Anyang 3
Asunción 3
Biên Hòa 3
Bursa 3
Totale 4.466
Salva come PNG Salva come JPEG
Nome #
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 116
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study 115
The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique 104
Integrating data from multidisciplinary Management of Malignant Pleural Mesothelioma: a cohort study 98
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 98
Non-invasive PD-L1 stratification in non-small cell lung cancer using dynamic contrast-enhanced MRI 97
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 97
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 95
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results 95
Whey protein isolate supplementation improves body composition, muscle strength, and treatment tolerance in malnourished advanced cancer patients undergoing chemotherapy 92
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 91
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 89
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias 89
Malignant pleural mesothelioma: Genetic and microenviromental heterogeneity as an unexpected reading frame and therapeutic challenge 88
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach 84
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG 84
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 84
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 80
To a new normal in radiation oncology: looking back and planning forward 79
Changes in breast cancer risk associated with different volumes, doses, and techniques in female Hodgkin's lymphoma patients treated with supra-diaphragmatic radiation therapy 78
The prognostic impact of BIA-derived fat-free mass index in patients with cancer 78
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 77
Back to (new) normality—A CODRAL/AIRO-L survey on cancer radiotherapy in Lombardy during Italian COVID-19 phase 2 77
Comparison of Gafchromic EBT2 and EBT3 for patient-specific quality assurance: Cranial stereotactic radiosurgery using volumetric modulated arc therapy with multiple noncoplanar arcs 76
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 76
COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS 75
Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum 72
Pulmonary function and quality of life after VMAT-based stereotactic ablative radiotherapy for early stage inoperable NSCLC: A prospective study 71
Postoperative Radiotherapy for Patients With Completely Resected Pathologic N2 Non-Small-Cell Lung Cancer: A Retrospective Analysis 69
Radiomics features as predictive and prognostic biomarkers in NSCLC 69
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 69
Definitive radiotherapy for localized follicular lymphoma staged by18F-FDG PET-CT: A collaborative study by ILROG 68
Intrathoracic core needle biopsy and repeat biopsy for PD-L1 evaluation in non-small cell lung cancer 68
Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach 68
COVID-19: Global radiation oncology's targeted response for pandemic preparedness 68
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 67
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations 66
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs 66
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 65
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa 64
Brain metastases from lung cancer: Is MET an actionable target? 63
A Strategy for Young Members within National Radiation Oncology Societies: the Italian Experience (AIRO Giovani Group) 63
Alternative options for elderly patients with limited stage diffuse large B-cell lymphoma: R-chemotherapy vs. R-chemotherapy plus radiotherapy 62
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC 61
Radiomics features as predictive and prognostic biomarkers in NSCLC 61
Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy 61
Outcomes of Single Fraction Stereotactic Ablative Radiotherapy for Lung Metastases 61
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 60
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA 60
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 59
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start? 57
Radiotherapy in Pediatric Oncology 57
Open issues in the therapeutic management of unresectable stage III NSCLC in the immunotherapy era 56
Extranodal Marginal Zone Lymphoma 56
Involved-Site Image-Guided Intensity Modulated Versus 3D Conformal Radiation Therapy in Early Stage Supradiaphragmatic Hodgkin Lymphoma 56
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation 56
Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia 56
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 55
Is clinical radiosensitivity a complex genetically controlled event? 55
PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy 54
Treatment of metastatic melanoma: a multidisciplinary approach 54
A young boy with ventricular arrhythmias and thyroid dysgenesis: two genes are not enough? 53
Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: An Italian multicenter observational study 53
Current role and future developments of radiotherapy in Hodgkin's lymphoma 51
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists – INTERACTION group 50
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease 50
Plan optimization for mediastinal radiotherapy: Estimation of coronary arteries motion with ECG-gated cardiac imaging and creation of compensatory expansion margins 50
Radiation therapy for older patients with brain tumors 49
Large cohort observational study integrates current knowledge on changes in outcome for melanoma brain metastases in tyrosine kinase inhibitor (TKI)-immunotherapy era 49
Stereotactic radiotherapy for early stage non-small cell lung cancer 48
No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer 48
Emo-linfopatie maligne 47
Stereotactic Ablative Radiation Therapy as First Local Therapy for Lung Oligometastases From Colorectal Cancer: A Single-Institution Cohort Study 47
Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG) 47
Stereotactic Ablative Radiotherapy for Pulmonary Oligometastases and Oligometastatic Lung Cancer 47
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 46
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: a systematic review 46
Peripheral blood complete remission after splenic irradiation in Mantle-Cell Lymphoma with 11q22-23 deletion and ATM inactivation 45
The "BUONGIORNO" Project: Burnout Syndrome Among Young Italian Radiation Oncologists 45
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 45
Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients 44
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological Malignancies 44
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial 43
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 43
Stereotactic ablative radiation therapy prior to liver transplantation in hepatocellular carcinoma 43
Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases 43
Limited stage follicular lymphoma: Current role of radiation therapy 43
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists 42
Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy 42
New concepts and insights into the role of radiation therapy in extracranial metastatic disease 42
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 41
Innovative technologies in thoracic radiation therapy for lung cancer 41
Stereotactic body radiation therapy for lung metastases 40
Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma 40
Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience 40
Optimized Volumetric Modulated Arc Therapy Versus 3D-CRT for Early Stage Mediastinal Hodgkin Lymphoma Without Axillary Involvement: A Comparison of Second Cancers and Heart Disease Risk 40
Prognostic role of pre-radiation therapy 18F-fluorodeoxyglucose positron emission tomography for primary mediastinal B-cell lymphomas treated with R-CHOP or R-CHOP-like chemotherapy plus radiation 40
Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies 39
Optimal Therapy for Early-Stage Hodgkin’s Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy 38
Radiotherapy and immune checkpoints inhibitors for advanced melanoma 37
Totale 6.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 1 1 31
2021/2022414 16 0 19 6 7 9 9 29 23 9 68 219
2022/20231.153 134 49 5 68 70 98 3 67 618 4 32 5
2023/2024617 59 67 71 37 73 193 56 12 0 23 1 25
2024/20251.337 43 121 34 47 19 60 46 53 367 73 124 350
2025/20262.911 217 228 273 309 372 129 631 211 341 200 0 0
Totale 6.672